Tarenflurbil Unknown Status Phase 2 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00045123R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence